Crescent Biopharma Inc.

NASDAQ: CBIO · Real-Time Price · USD
13.89
-0.04 (-0.29%)
At close: Aug 15, 2025, 3:59 PM
14.06
1.19%
After-hours: Aug 15, 2025, 07:27 PM EDT

Crescent Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025
Period Ending Jun 30, 2025
Revenue
153.3M
Cost of Revenue
4.83M
Gross Profit
148.47M
Operating Income
5.63M
Interest Income
97K
Pretax Income
13.77M
Net Income
21.08M
Selling & General & Admin
107.28M
Research & Development
28.65M
Other Expenses
972K
Operating Expenses
136.91M
Interest Expense
1.07M
Selling & Marketing Expenses
82.05M
Cost & Expenses
141.74M
Income Tax Expense
-7.31M
Shares Outstanding (Basic)
n/a
Shares Outstanding (Diluted)
n/a
EPS (Basic)
50.25
EPS (Diluted)
42.31
EBITDA
22.29M
EBIT
-20.72M
Depreciation & Amortization
9.51M